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Abstract
Novel markers for ischemic heart disease are under investigation by the scientific community at international level.
This work focuses on a specific platelet membrane fatty acid condition of viscosity which is linked to molecular
aspects such as serotonin and G proteins, factors involved in vascular biology.
A suggestive hypothesis is considered about the possibility to use platelet membrane viscosity, in relation to sero-
tonin or, indirectly, the fatty acid profile, as indicator of ischemic risk.
Background
Because of peculiar characteristic of platelet in depres-
sion and in ischemic heart disease [1-4], we have first
investigated the platelet fatty acid profile in 50 subjects
with diagnosis of ischemic heart disease, 60 subjects in
health clinic conditions, 84 subjects with clinical diagno-
sis of Major Depression [5-7].
The fatty acids values of the 3 populations have been
administered to a Self Organizing Map (SOM), mixing
healthy and pathological individuals and hidding the
information on to their own pathological condition. As
a result, the SOM, after having identified the fatty
acids markers (Palmitic, Linoleic and Arachidonic for
depression and Oleic, Linoleic and Arachidonic for
ischemia), was able to map the three populations
(depressive vs normal and ischemic vs normal) using
the specific fatty acids, recognizing as similar those
belonging to the same population and, in the mean-
while, different those belonging to one population
from the other ones [5-7].
After the experiment, to classify other groups of sub-
jects, the platelet fatty acid pattern has been analyzed in
80 subjects with Morphea, in 31 subjects with Sclero-
derma and in 45 young people, in healthy clinical condi-
tions, for a total of 350 subjects.
Concept of chemical-physical membrane state
In the case of biological membranes we use the terms of
“fluidity”, “stiffness,” permeability “functionality”,a n d
“stickiness”, related or connected with biological effects
of considerable importance.
Fluidity and viscosity are two terms used in physics
with specific meaning: the viscosity is a dynamic prop-
erty of matter and is defined as the skid resistance of
two fluid layers between them, in a real system treated
as a package of fluid layers superimposed (in slow linear
motion), which can vary with temperature for the same
molecules, while the fluidity is the opposite.
Rigidity, permeability and function are, however, char-
acteristics of the membrane and are terms used to
describe a physical and biological membrane behavior
on the physiology of the cell. The viscosity of the mem-
brane, of course, is related to the composition of fatty
acids constituting the lipid bilayer (membrane folds).
With reference to the membrane folds, they are
usually very close and the distance may be very small in
the case of saturated fatty acids, distance which tends to
increase, replacing these with unsaturated fatty acids,
much more as they are unsaturated.
Membrane viscosity and serotonin
It has been demonstrated that the membrane viscosity is
a peculiar characteristic in depressive subjects [7,8] and
that regulates serotonin receptors uptake [9].
Among all its function serotonin is also involved in
some aspects of cardiac events such as coronary artery
disease, in aggregation and vasoconstriction [10,11].
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nin transporters and it is, then, secreted by the platelet
dense granules during platelet activation, playing a role
in platelet aggregation and vasoconstriction of surround-
ing blood vessels. Recent studies suggest that intracellu-
lar serotonin may also play a role in platelet activation
through covalent linkage to small G proteins, activating
G protein signaling pathways and stimulating platelet
aggregation [12].
Total serotonin levels and the number of platelets
have been found significantly higher among patients
whith coronary artery disease [11].
Hypothesis
Independently of the SOM results, among all the fatty
acid profiles, three fatty acids (Palmitic, Linoleic and
Arachidonic), unexpectedly, had a constant total amount
(53. 33 ± 3.43) representing the larger amount of plate-
let membrane fatty acids in all cases studied.
Being the Palmitic Acid opposed to Linoleic Acid and
to Arachidonic Acid (Table 1), according to the satura-
tion and unsaturation characteristics, it has been possible
to calculate a coefficient, called B3 (Table 2), which gives
an indication of viscosity, using the following formula:
B( A
MeltingPointi
MolecularWeighti
) 2i
i1
3
=
= ∑
Where:
Ai = percentage of i-th Fatty Acid
mwi = molecular weight of i-th Fatty Acid
mpi = melting point of i-th Fatty Acid (°C)
T h er e s u l ti sc o n s i s t e n tw i t ht h ek n o w l e d g et h a tc o r -
relates platelet membrane viscosity and function, in the
conditions investigated (normal, ischemic and depressive
subjects).
T h i sc o u l dl e a dt ot h ei d e ao fan e wi s c h e m i cr i s k
assessment, considering each fatty acid concentration,
within the same total percentage.
Implication of the hypothesis
As shown in table 2 the B3 index is significantly higher
( a b o u t3 0 % )i ni s c h e m i ct h a ni nn o r m a ls u b j e c t sa n d3
times higer than in depressive subjects.
For the properties that link membrane viscosity to the
platelet serotonin receptor uptake and for the role of
s e r o t o n i ni nc o r o n a r ya r t e r y disease, the evaluation of
the chemical-physical characteristic should be utilized to
forecast the ischemic risk, in agreement with the experi-
mental results obtained in ischemic heart disease sub-
jects through the SOM use [6,7].
Recent studies have, also, pointed out alterations of
endocannabinoids (arachidonate derivatives) in human
platelets during various human pathologies and in rela-
tion to serotonin and depression [13-18]. The informa-
tion contained in these works seems relevant to the
reported data and support the proposed hypothesis.
Conclusion
In our opinion, studies on gene expression and molecu-
lar aspects of platelets, in ischemic heart disease, should
take into account the membrane fatty acids ratio and its
viscosity.
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Table 1 Description of the fatty acids considered
i Name
1 Palmitic Acid C 16:0
2 Linoleic Acid C 18:2
3 Arachidonic Acid C 20:4
Table 2 Value of the B3 index in the subjects studied
Fatty acid MP/Mwt Normal subjects
(average ± SD)
B3 index Depressive
(average ± SD)
B3 index Ischemic
(average ± SD)
B3 index
C 16:0 0.246 20.68 ± 2.15 5.089 17.92 ± 4.462 4.408 23.32 ± 3.17 5.737
C 18:2 n6 -0.018 19.40 ± 2.69 -0.348 16.71 ± 3.359 -0,301 10.51 ± 3.44 -0.189
C 20:4 n6 -0.164 14.06 ± 2.41 -2.306 19.03 ± 3.839 -3.121 15.17 ± 3.01 -2.488
2,434 0.986 3.060
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